HCPLive Endocrinology

#TLM24 may be over, but you can still keep up with the latest news, research, and expert perspectives from the meeting by following along with our coverage: hcplive.com/conference/liv…

BREAKING: The US Food and Drug Administration has issued a Complete Response Letter to Intercept Pharmaceuticals’ obeticholic acid (Ocaliva) for the treatment of #PBC, denying to approve the supplemental New Drug Application in its current form. hcplive.com/view/fda-issue…

“What we learned from FLOW is semaglutide saves kidneys, hearts, and lives” Final on-site episode of #KidneyCompass from #KidneyWk. Check out our earlier episodes using the link below 👇 hcplive.com/podcasts/kidne…

What is the difference between Chat GPT-3.5 and GPT-4 in the diagnosis of skin disease among those in non-skin of color and skin of color patient groups? Check out these new findings here: hcplive.com/view/study-com… #dermatology

🚨 Breaking News!🚨 @EliLillyandCo's tirzepatide showed a 38% reduction in heart failure outcomes and improved symptoms in adults with HFpEF and obesity, according to topline data from the phase 3 SUMMIT trial. Learn more: lnkd.in/ej2spXfh #Obesity #HeartFailure

🔒HCPLive exclusive: Adelina Hung, MD, of @ChicagoMedEdu @SinaiChicago, discusses innovations in #GERD and the FDA approval of vonoprazan (Voquezna) for non-erosive GERD. 👇 Check out a sneak peek below and sign up to access the full episode: hcplive.com/view/innovatio…

Big weekend in Orlando at #ADASciSessions. Quick 🧵 on top headlines through Sunday: hcplive.com/conference/ada #Diabetes #Obesity @ADA_DiabetesPro

Catch up on day one from ADA 2024!

Last-minute packing for #ADA24 and then off to Orlando! Super excited to see new data on tirzepatide, inhaled insulin, the CATALYST trial, and more this weekend! Follow on @HCPLiveNews for the latest updates! hcplive.com/conference/ada

New #DontMissABeat Fresh off #ERA24, @BrendonNeuen joins @MVaduganathan & @SJGreene_MD to discuss semaglutide, FLOW, and the future of cardiorenal protection. hcplive.com/view/dont-miss… #Nephrology #Cardiology

"We used a claims database to evaluate the risk of postoperative respiratory complications among patients with #diabetes and a prescription fill for GLP-1 RAs." hcplive.com/view/glp-1-rec…

In the latest #DiabetesDialogue, @AlanLotvinMD joins @DianaMIsaacs and @natalie_bellini to discuss what the #diabetes community needs to know about the latest FDA-cleared automated insulin delivery system: Sequel Med Tech's twiist. Full episode: hcplive.com/view/diabetes-…

Part 2 of the Question List:

🚨 We are just days away from our #PreACCChat with @APAC_Cardiology on April 1 from 8-9 PM ET ! 🚨 Check out our 10 questions and posting times to prepare for the evening and participate on Monday night! #CardioTwitter #Cardiology #ACC24 Part 1:

Get a recap of top news and data related to automated insulin delivery from #ATTD2024 in the latest episode of #DiabetesDialogue! hcplive.com/view/diabetes-…

ACC.24 Tweet Chat on Monday from 8-9 PM from @HCPLiveNews and @APAC_Cardiology!! Questions list posted tomorrow on: hcplive.com/view/hcplive-a… #Cardiology #Cardiotwitter #ACC24

🚨 We are 10 days away from our pre-ACC Tweet Chat with @APAC_Cardiology! 🚨 Join us on April 1 at 8 PM ET for a 10-question tweet chat discussing all things #ACC24, including the most anticipated sessions, pressing research needs, and more! hcplive.com/view/hcplive-a… #Cardiology

In this episode of #DiabetesDialogue, @brendonneuen joins @DianaMIsaacs & @natalie_bellini talk about the FLOW trial, the concept of 4 pillars of GDMT for CKD in T2D, and how to approach sequencing of new therapies. hcplive.com/view/diabetes-… #ChronicKidneyDisease #Diabetes

"The future is so bright. We're in a unique period in medicine" SURMOUNT-2 lead Dr. Garvey on the future of incretin therapies, including tirzepatide, retatrutide, survodutide & CagriSema, in the latest #DiabetesDialogue. hcplive.com/view/diabetes-… @DianaMisaacs @natalie_bellini

How does SELECT change management of CV risk? In the latest #DiabetesDialogue special guest @LincoffMichael joins @DianaMIsaacs and @natalie_bellini to discuss SELECT, its implications, and the future of incretin therapies. hcplive.com/view/diabetes-… #Obesity #Diabetes #Cardiology